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Abstract
Background: The ciliopathies represent an umbrella group of >50 clinical entities that share both clinical features
and molecular etiology underscored by structural and functional defects of the primary cilium. Despite the advances
in gene discovery, this group of entities continues to pose a diagnostic challenge, in part due to significant genetic
and phenotypic heterogeneity and variability. We consulted a pediatric case from asymptomatic, non-consanguineous
parents who presented as a suspected ciliopathy due to a constellation of retinal, renal, and skeletal findings.
Results: Although clinical panel sequencing of genes implicated in nephrotic syndromes yielded no likely causal
mutation, an oligo-SNP microarray identified a ~20-Mb region of homozygosity, with no altered gene dosage, on
chromosome 16p13. Intersection of the proband’s phenotypes with known disease genes within the homozygous
region yielded a single candidate, IFT140, encoding a retrograde intraflagellar transport protein implicated previously in
several ciliopathies, including the phenotypically overlapping Mainzer-Saldino syndrome (MZSDS). Sanger sequencing
yielded a maternally inherited homozygous c.634G>A; p.Gly212Arg mutation altering the exon 6 splice donor site.
Functional studies in cells from the proband showed that the locus produced two transcripts: a majority message
containing a mis-splicing event that caused a premature termination codon and a minority message homozygous for
the p.Gly212Arg allele. Zebrafish in vivo complementation studies of the latter transcript demonstrated a loss of
function effect. Finally, we conducted post-hoc trio-based whole exome sequencing studies to (a) test the possibility of
other causal loci in the proband and (b) explain the Mendelian error of segregation for the IFT140 mutation. We show
that the proband harbors a chromosome 16 maternal heterodisomy, with segmental isodisomy at 16p13, likely due to a
meiosis I error in the maternal gamete.
Conclusions: Using clinical phenotyping combined with research-based genetic and functional studies, we have
characterized a recurrent IFT140 mutation in the proband; together, these data are consistent with MZSDS. Additionally,
we report a rare instance of a uniparental isodisomy unmasking a deleterious mutation to cause a ciliary disorder.
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Background
Genetic medicine in the post-genome era has benefited
from increasingly sophisticated methodologies to detect
both chromosomal lesions, as well as point mutations
across subsets of functionally related genes, or indeed
the entire genome [1]. Such approaches are particularly
useful for human genetic conditions that are unified by a
common cellular basis, but for which extensive pheno-
typic variability and genetic heterogeneity pose clinical
diagnostic challenges. The ciliopathies—multi-systemic
disorders caused by dysfunction, altered assembly, and/
or altered maintenance of cilia—exemplify a class of
inherited disorders which have achieved accelerated
molecular discovery in the past ~15 years in part from
the advent of whole exome sequencing (WES) and
chromosomal array technologies [2–5].
Given the near ubiquitous presence of cilia on differ-
ent cell types of the vertebrate body plan, it is not
surprising that mutations in genes critical for ciliary
function can give rise to a broad range of phenotypic
features, often characterized by developmental defects in
single or multiple systems [6–8]. Some estimates suggest
that ~1000 proteins may localize to or be required for
ciliary processes [9], thus representing a substantial mu-
tational target. Within the ciliary organelle, macromol-
ecular complexes that perform discrete functions have
been characterized biochemically; these include the
intraflagellar transport (IFT) complex [10], BBSome [11],
and transition zone complex [12], and some phenotype
correlations with these complexes have emerged [13].
For example, the skeletal ciliopathies, including Jeune
asphyxiating thoracic dystrophy (JATD; MIM 208500),
short-rib polydactyly (SRP; MIM 208500), Sensenbrenner
syndrome (MIM 218330), and Mainzer-Saldino syndrome
(MZSDS; MIM 266920) are enriched for mutations in
genes involved in IFT, especially retrograde transport
(IFT-complex A). For example, Sensenbrenner syndrome
(also known as cranioectodermal dysplasia [14]), a ciliopa-
thy characterized by sagittal craniosynostosis with accom-
panying facial, skeletal, and ectodermal anomalies, is
caused by mutations in the IFT-A genes IFT43 [15],
WDR35 [16], IFT122 [17], WDR19 [18], and IFT140 [19].
Similarly, the neonatal lethal JATD [20] is hallmarked by a
constricted thoracic cage, shortening of the long bones,
polydactyly, renal cystic disease, hepatic insufficiency, and
retinal degeneration in the individuals who survive past
birth. Like Sensenbrenner, JATD can also be caused by
mutations in retrograde IFT components, including the
motor DYNC2H1 [21, 22] and IFT-A genes TTC21B [23],
WDR19 [18], and IFT140 [24]. However, neither of these
two ciliopathies is caused exclusively by IFT-A dysfunc-
tion; for example, JATD can be caused by mutations in
the anterograde IFT genes (complex B) IFT80 [25] or
IFT172 [26]. Furthermore, recessive mutations in a causal
gene might not necessarily give rise to a skeletal pheno-
type, adding further complexity to genotype-phenotype
correlations within the skeletal ciliopathies. For example,
mutations in IFT172 can also cause syndromic or non-
syndromic retinal degeneration [27].
Here, we report a pediatric case with hallmark retinal,
renal, and skeletal phenotypes whose molecular diagno-
sis was initially unclear. Multi-tiered in vitro and in vivo
functional studies suggested that loss of function of
IFT140 is the likely driver, as caused by a combination
of mis-splicing and reduction to homozygosity of a
missense variant through a uniparental isodisomy mechan-
ism. Together, these results support a diagnosis of
MZSDS, represent a rare example of a ciliopathy caused
by a non-Mendelian mutational mechanism, and reinforce
the need to examine all possible mutation inheritance par-
adigms when analyzing diagnostic exomes.
Results
Case report
We consulted a 5-year-old male proband who had a his-
tory of complex medical issues, including the following
triad of symptoms: retinal dystrophy, acute-onset renal
failure, and joint pain (Fig. 1; Additional file 1: Figure S1;
Table 1). He was the product of a normal pregnancy with
no known teratogenic exposures and was born at term via
induced vaginal delivery from his 38-year-old G5 P3-P4
mother. He had a normal birth weight of 3543 g, was mea-
sured 48 cm in length, and was the fourth child born to a
non-consanguineous couple of northern European ances-
try (Fig. 2a). Both parents and all older siblings (two males
and one female) were reported healthy. The extended
family history was also unremarkable, with the exception
of a paternal family history of type 1 diabetes, a paternal
grandmother with alpha-1-antitrypsin deficiency, and a
maternal cousin who was reported to have hearing loss
and retinitis pigmentosa of unknown etiology. The pro-
band reached his developmental milestones on time;
although, there were some mild difficulties with visual
tracking and speech articulation.
At 3 years of age, the proband was referred to an oph-
thalmologist for concerns of nyctalopia, high myopia,
and continued poor visual tracking. Fundus exams and
electroretinograms (ERG) revealed a rod-cone dystrophy
in both eyes with mottling of the retinal pigmentary
epithelium and dystrophy of the internal limiting
membrane (Additional file 1: Figure S1). The fundus
photos show non-specific subretinal hypopigmentation
consistent with early onset retinal degeneration typical of
rod-cone dystrophies (Additional file 1: Figure S1a). The
retinal vasculature appeared attenuated in both eyes.
There was no relative afferent pupillary defect and no nys-
tagmus. His high myopia was progressive. At 5 years of
age, his refraction was −4.5 and −6.75 diopters in the right
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and left eyes, respectively. By the age of 8 years old, his
best-corrected visual acuity was 20/50 OD and 20/50 OS
with glasses and his refraction had increased to −10.25
+2.75 ×106 OD and −11.00 +1.50 ×61 OS. The ERG testing
demonstrated reduced cone function under photopic con-
ditions with reduced a-wave implicit time and amplitudes
and slowed implicit times for the b-wave (Additional file
1: Figure S1b). Under scotopic testing, both a-waves and
b-waves showed slower implicit time and diminished am-
plitudes (Additional file 1: Figure S1c). The a-wave was
substantially delayed, and there were reduced incremental
increases in a-wave and b-wave. Audiometric testing was
normal bilaterally.
In addition to retinal dystrophy, the proband devel-
oped acute-onset renal failure. Initial symptoms included
pulmonary edema, severe hypertension, and fluid over-
load requiring hemodialysis. At 5 years of age, he was
transitioned to peritoneal dialysis and remained on dialy-
sis for 5 months, until he received a living related donor
kidney transplant. A renal biopsy of the diseased kidney
confirmed the cause of renal failure: histological analyses
showed diffuse severe tubulointerstitial fibrosis with
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Fig. 1 Radiographic and renal features of the proband. a Photograph of the index case at 10 years of age. b Radiograph of the left (L) hand at 5 years
and 1 month of age shows cup-shaped metaphyses (blue arrowheads), cone-shaped epiphyses (yellow arrowheads), and short metacarpals. Bone age is
consistent with chronological age. c Radiograph of right (R) foot at 5 years and 1 month of age shows shortened proximal phalanges with cup-shaped
metaphyses (blue arrowhead) and short metatarsals with irregular metaphyses. d Radiograph of the right (R) femur showed bilateral coxa valga, broad
femoral necks, abnormal femoral metaphyses, and mild bowing of the femoral diaphysis. e Renal glomeruli with prominent, periglomerular fibrosis;
hematoxylin and eosin (H&E) stain; scale bar, 50 μm. f Tubulointerstitial fibrosis, chronic inflammation, tubular atrophy, and focal non-atrophic tubules,
(upper right of panel); H&E; scale bar 50 μm. g Diffuse, severe tubulointerstitial fibrosis and tubular atrophy; Masson’s trichrome stain; scale bar 100 μm.
h Focal non-atrophic proximal tubules with segmentally thin and duplicated (arrows) basement membranes; periodic acid-Schiff stain; scale bar 20 μm
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Table 1 Phenotype summary
Case reported here
(DM165-0001)
Family V-1
(Perrault et al. 2012) [24]
Family V-2
(Perrault et al. 2012) [24]
Family VII-1
(Perrault et al. 2012) [24]
Sex M M F M
Age at
examination
5 years 4 years; 10 years 2 years; 4 years Birth; 8 months;
12 months; 18 months
IFT140 allele 1 c.634G>A
(p.Gly212Arg)
c.634G>A
(p.Gly212Arg)
c.634G>A
(p.Gly212Arg)
c. 2399+1G>T (splice)
IFT140 allele 2 c.634G>A
(p.Gly212Arg)
c.3916dup
(p.Ala1306Glyfs*56)
c.3916dup
(p.Ala1306Glyfs*56)
c. 634G>A
(p.Gly212Arg)
Diagnosis Mainzer-Saldino syndrome Mainzer-Saldino syndrome Mainzer-Saldino syndrome Jeune syndrome
(MIM 266920) (MIM 266920) (MIM 266920) (MIM 208500)
Psychomotor
development
Dysgraphia Normal Normal Hypotonia
(HP:0010526), (HP:0001290),
Reading difficulties Poor feeding at birth
(HP:0010522), (HP:0008872),
Adjustment disorder with mixed Developmental delay
disturbance of emotions
and conduct
(HP:0001263)
(HP:0100851)
Cerebral MRI NA Normal Normal Normal
Retina
Nystagmus No No No Yes
(HP:0000639)
Refraction High myopia Myopia NA NA
(HP:0011003) (HP:0000545)
Light behavior Nyctalopia NA NA NA
(HP:0000662)
Visual field NA Tubular NA NA
(HP:0030588)
Visual acuity Mild difficulty with visual tracking 60/200 RE; 120/200 LE
with color vision
120/200 RE;100/200 LE Able to fix and follow
(HP:0030532)
Fundus Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa NA
(HP:0000510) (HP:0000510) (HP:0000510)
ERG Rod-cone dystrophy Severely altered Severely altered NA
Craniofacial
features
No obvious facial dysmorphisms Craniosynostosis Craniosynostosis Normal
(HP:0001363), (HP:0001363),
Scaphocephaly Scaphocephaly
(HP:0030799), (HP:0030799),
Facial dysmorphism Facial dysmorphism
(HP:0001999) (HP:0001999),
Microcephaly
(HP:0000252)
Stature 120.2 cm (50th centile) at
6 years and 11 months
Short Short Normal
(HP:0004322) (HP:0004322)
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Table 1 Phenotype summary (Continued)
Limbs
Hands Cone-shaped epiphyses
of phalanges
Cone-shaped epiphyses
of phalanges
Cone-shaped epiphyses
of phalanges
Cone-shaped epiphyses
of phalanges
(HP:0010230), (HP:0010230), (HP:0010230) (HP:0010230)
Brachydactyly
(HP:0011927),
Normal bone age
Feet Shortened metacarpals NA NA NA
(HP:0010049),
Shortened proximal phalanges
(HP:0001831),
Shortened metatarsals
(HP:0010743),
Irregular proximal metatarsal
metaphyses
(HP:0010630),
Brachydactyly
(HP:0001831)
Long bones Abnormal proximal femoral
metaphyses
NA NA Trident acetabulum
(HP:0003170)
(HP:0003411),
Sclerotic changes of the of
proximal femoral growth plate
(HP:0008797),
Broad femoral necks
(HP:0006429),
Mild bowing of the
femoral diaphysis
(HP:0002980)
Other skeletal Small left joint effusion of the hip NA NA Short thorax
(HP:0001384), (HP:0010306),
Bilateral coxa vara Short ribs
(HP:0002812) (HP:0000773)
Renal features
Function Acute-onset renal failure (5 years) Chronic renal failure
(4 years)
Chronic renal failure (9 months) Elevated urea
(HP:0001919); (HP:0000083), (HP:0000083); (HP:0000093
End-stage renal disease
(15 years)
End-stage renal disease
(3 years)
Proteinuria (18 months)
(HP:0003774) (HP:0003774) (HP:0000093)
Ultrasonography Pre-transplant renal ultrasound: Cysts, Small kidneys (-1DS) 1 cyst (cortico-medullar,
right
Increased echogenicity
No evidence of hydronephrosis,
Renal cortical medullary
parenchymal disease
(HP:0000107) kidney) (HP:0004719)
Hyperechogenicity (HP:0000107)
(HP:0004719), Hyperechogenicity
(HP:0025327) Cortico-medullary
differentiation loss
(HP:0004719),
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tubular atrophy and only focal non-atrophic tubules
(Fig. 1e, f ). Half of the 14 glomeruli examined were ob-
solescent. The remaining glomeruli appeared partially
collapsed and some had segmental capsular adhesion
and scarring. Non-obsolescent glomeruli had periglo-
merular fibrosis with an onion skin-like appearance
(Fig. 1g), as evidenced by Masson’s trichrome staining.
The tubulointerstitium contained a patchy infiltrate of
lymphocytes, and eosinophils were present focally.
Periodic acid-Schiff stain (PAS) showed that non-atrophic
tubules had segmentally thick and thin tubular basement
membranes and segmental duplication (Fig. 1h). Together,
these data were suggestive of nephronophthisis [28];
although, we did not detect tubular cysts in the sampled
tissue; this may have reflected an absence of the cortico-
medullary junction in the biopsy. Electron microscopy
also showed tubular basement membranes that were
focally thick or thin. Arteries were normal and arterioles
had mild sclerosis. Except for some segmental entrapment,
glomeruli were negative for IgG, IgA, IgM, C3, and
C1q by direct immunofluorescence (not shown),
ruling out the possibility of C1q steroid-resistant
nephrotic syndrome [29].
At the time of the initial evaluation, the proband also
reported joint pain with popping of the knees and hips
bilaterally. An X-ray bone age study of the hand showed
cone-shaped epiphyses of all phalanges with shortened
metacarpals and otherwise normal bone age (Fig. 1b).
The lower proximal phalanges were short with cup-
shaped metaphyses, and the metatarsals were also short
(Fig. 1c). Imaging of the knees was normal; however,
radiographs of the lower extremities showed bilateral
Table 1 Phenotype summary (Continued)
Cortico-medullary
differentiation
Pre-transplant abdominal
ultrasound: Echogenic
kidneys bilaterally
(HP:0005565) loss
Growth retardation
(-2DS)
(HP:0005565)
(HP:0004719) (HP:0000089) Growth retardation
Post-transplant renal ultrasound:
Normal transplanted kidney,
normal bladder, atrophic
appearance of native kidney
(HP:0000089)
Biopsy Diffuse severe tubulointerstitial
fibrosis
Non-specific tubulointerstitial
nephritis
(HP:0001970)(HP:0005576)
Tubular atrophy
(HP:0000092
Only focal non-atrophic tubules
Liver Pre-transplant abdominal
ultrasound: Hepatomegaly
Moderate cholestasis Moderate cholestasis NA
(HP:0001396) (HP:0001396)
(HP:0002240) Hepatic cytolisis
with hepatomegaly
Possible fatty infiltration
(HP:0001397) (HP:0002240),
Portal fibrosis
(HP:0006580)
Other Pulmonary edema Bilateral hypoacousia
(HP:0100598), (HP:0000407)
Severe hypertension
(HP:0000822),
Fluid overload
(HP:0011105);
Mild sclerosis of arterioles
(HP:0002634)
NA not available
Helm et al. Human Genomics  (2017) 11:16 Page 6 of 14
coxa vara, abnormal femoral metaphyses, and sclerotic
changes along the metaphyseal side of the femoral
growth plate (Fig. 1d). There was broadening of the
femoral necks and mild bowing of the femoral diaphysis.
Although we could not rule out that some of the joint
pain was caused by renal osteodystrophy, the radio-
graphic studies suggested metaphyseal dysplasia. At the
time of the most recent examination (6 years and
11 months), the proband weighed 28.8 kg (90th centile),
had a height of 120.2 cm (50th centile), and had a
fronto-occipital circumference of 52.7 cm (50th centile).
A physical exam showed well-healed scars over his
abdomen from prior surgeries, with a G-tube in place.
His hands showed brachydactyly with shortened distal
phalanges, and his facial appearance was not overtly
dysmorphic (Fig. 1a). The remainder of the physical
examination was otherwise unremarkable.
Candidate gene analysis identifies IFT140 as the likely
causal gene
Prompted by the acute renal failure of the proband, we
conducted clinical panel sequencing of genes implicated
in renal conditions (Additional file 1: Table S1). First, we
screened six genes that cause nephrotic syndrome or glo-
merulosclerosis [30–37]. No sequence alterations were
identified in NPHS2, LAMB2, ACTN4, or TRPC6. In
WT1, a gene known to be associated with autosomal
dominant nephrotic syndrome [32, 36], we identified a
heterozygous, intronic variant (c.1099-9T>C); although
rare, its frequency in presumably healthy controls in the
Exome Aggregation Consortium (ExAC) database indi-
cated that it is likely a benign variant (0.004 minor allele
frequency (MAF); 4 homozygotes in 120,852 individuals).
Additionally, we detected a rare heterozygous missense
change in NPHS1 (c.1175T>C; p.Leu392Pro) deemed simi-
larly as likely benign due to the presence of healthy homo-
zygous individuals in ExAC (18 of 121,144 samples). Next,
we carried out clinical genetic testing of another five genes
known to cause the isolated or syndromic renal ciliopathies,
nephronophthisis or Senior-Løken syndrome, respectively
[38–42]. We identified a missense change that was com-
mon in healthy controls (>1% MAF; SDCCAG8), three
synonymous variants (GLIS2, IQCB1, SDCCAG8), and two
deep intronic variants (IQCB1 and INVS), all of which were
considered likely benign (Additional file 1: Table S1).
We next considered the possibility that the proband
might harbor chromosomal aberrations. We therefore con-
ducted an oligonucleotide (oligo)-single nucleotide poly-
morphism (SNP) microarray (Affymetrix 6.0). We identified
a ~20-Mb region of homozygosity on 16p13.3p12.3 (hg19,
chr16:94,807-20,250,946; Fig. 2b). This region encompasses
411 genes, 44 of which are associated currently with disease.
When we intersected the clinical synopsis of each disease-
related gene with the phenotypes of the proband, we
da
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Fig. 2 Clinical and research-based genetic analysis. a Pedigree of family DM165. b Schematic of human chromosome 16. The ~20 Mb region of
homozygosity identified in the proband is outlined with a red rectangle. The genomic location of IFT140 is indicated with a red star. The 823
variants extracted from the exome data are indicated as homozygous (HOM; red) or heterozygous (HET; blue); pale blue circles indicate homozygous
variants of unambiguous maternal origin (n = 111). c Sequence chromatograms identified a homozygous IFT140 c.634G>A; p.Gly212Arg mutation that
does not segregate in a Mendelian fashion. The mutation location at the exon 6 canonical splice donor site is indicated with a red star. d Expanded
representations of chr16p in each of the proband, maternal, and paternal samples. Colors are indicated as described for panel b
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identified a single likely candidate, IFT140. This locus
encodes a component of the retrograde intraflagellar trans-
port complex [10]. Crucially, mutations in IFT140 cause a
spectrum of ciliopathies, including MZSDS [24], JATD [24],
syndromic and non-syndromic retinal dystrophy [43–45],
Opitz trigonocephaly C syndrome [46], and Sensenbrenner
syndrome [19]. To investigate the possibility that mutations
in IFT140 could contribute to the proband’s clinical presen-
tation, we conducted research-based Sanger sequencing of
the 29 coding exons and intron-exon boundaries. We iden-
tified a single rare homozygous variant at the exon 6 donor
splice site (NM_014714.3: c.634G>A; p.Gly212Arg) in the
proband (Fig. 2c). This change is ultra-rare in publicly
available control datasets (5/121,320 alleles in ExAC, all
heterozygous), and, notably, has been reported in three
individuals from two unrelated families with skeletal ciliopa-
thies [24] (Table 1). Segregation of the c.634G>A variant in
both parents revealed a Mendelian violation: his mother
was a heterozygous carrier, but his father was wild type at
the same genomic position (Fig. 2c).
Functional studies of the IFT140 c.634G>A variant
indicate loss of function
We considered two mechanisms by which the c.634G>A
variant could ablate the function of IFT140: (1) disrup-
tion of mRNA splicing by abolishing the canonical
donor spice site and (2) diminished protein function due
to an amino acid alteration of a conserved residue pre-
dicted to reside within a WD40 domain (Fig. 3a). We
tested both hypotheses.
First, to investigate whether c.634G>A results in
aberrant IFT140 mRNA processing, we established
lymphocyte cell lines (LCL) from a whole-blood sample
from the proband and we monitored mRNA splicing.
We harvested total RNA from proband LCLs and
matched control LCLs, reverse transcribed to generate
cDNA, and PCR-amplified a 461-bp region spanning
exons 4–8 of the canonical IFT140 transcript. In com-
parison to the expected sized amplicon in the control
sample, we observed two different-sized PCR products
in the proband (Fig. 3b). Sequencing revealed that the
b
a
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Fig. 3 In vitro and in vivo functional analysis of IFT140 c.634G>A; p.Gly212Arg. a Schematic of the human IFT140 locus at chr16:1,510,427-1,612,110
(hg19; top) and translated protein (bottom). Exons are depicted as green boxes; untranslated regions are shown as white boxes (NM_014714.3). Protein
schematic (blue; NP_055529.2) indicates predicted WD40 repeat (WD40) and tetratricopeptide-like helical domains (TPR). IFT140 c.634G> A; p.Gly212Arg
location is indicated with a red star. b RT-PCR from proband lymphocyte cell lines indicating aberrant mRNA splicing. IFT140 cDNA was amplified with
primers flanking the exon 6 canonical splice donor site (black arrows). Sequence chromatograms from purified PCR product indicates that the majority
of IFT140 message is missing exon 6 (bottom). c Lateral (top) and dorsal (bottom) views of ift140 morphants exhibiting gastrulation defects. d In vivo
complementation studies. Live embryo batches were scored to assay variant pathogenicity. Class I, modest shortening of the body axis and reduction
in size of anterior structures; class II, severe shortening of the body axis and decreased anterior structures accompanied by broadening and/or kinking
of the notochord and thinning of the somites. To compare pairs of embryo batches, χ2 tests were used; p < 0.0001 indicated with (asterisk)
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smaller splice variant was missing the 143-bp IFT140
exon 6, resulting in a transcript that shifts the reading
frame and results in a stop codon at residue 171. The
larger mRNA species amplified from proband cDNA
was equivalent in size to that of the control, but har-
bored the c.634G>A mutation (Fig. 3b). Although we do
not know whether this correctly spliced mRNA would
give rise to a stable or functional protein, the p.Gly212
position is conserved (present in all vertebrates to Danio
rerio) and p.Gly212Arg is predicted to be probably dam-
aging (PolyPhen-2; score of 1). Together, our in vitro
studies revealed the production of two different IFT140
mRNA species, one resulting in an unambiguous loss of
function and another harboring a candidate pathogenic
missense variant.
We have shown previously that suppression of both
anterograde and retrograde IFT proteins in zebrafish re-
sults in gastrulation defects in mid-somite stage embryos
[4, 23, 47, 48] and that an assay of missense variants
through an in vivo complementation approach [49] is
highly concordant with in vitro cilia length complemen-
tation studies [23, 47]. We therefore used this approach
to test the pathogenic potential of IFT140 c.634G>A;
p.Gly212Arg. Reciprocal BLAST identified a single zeb-
rafish IFT140 ortholog (59% identity; 76% similarity ver-
sus human IFT140), which we suppressed with a
previously validated morpholino (MO) [50] that targets
the exon 2 splice donor site of the D. rerio transcript
(GRCz10; ENSDART00000129889.4; Additional file 1:
Figure S2a-c). We injected progressively increasing doses
of splice-blocking MO (sb-MO) into embryos at the
one-to-four-cell stage (3, 6, and 9 ng; n = 59–70 em-
bryos/injection batch, repeated twice; Additional file 1:
Figure S2d). First, we scored live embryos for gastrula-
tion defects at the nine somite stages according to estab-
lished scoring criteria (class I is defined as having a
shortened anterior-posterior body axis with small anter-
ior structures and mild somite defects; class II is defined
as having a severely shortened body axis, severely af-
fected anterior structures, broadening and kinking of the
notochord, thinning and widening of the somites, and
tail extension defects [4, 23, 47]; Fig. 3c). We observed
dose-dependent defects (Additional file 1: Figure S2d).
Co-injection of 100 pg WT human IFT140 mRNA with
8 ng sb-MO resulted in a significant rescue of gastrula-
tion defects (21 versus 62% affected for WT rescue com-
pared to MO alone; p < 0.0001; Fig. 3d). Next, we
compared the ability of equivalent doses of IFT140 WT
or p.G212R-encoding mRNA to rescue the MO-
induced gastrulation defects observed at the mid-
somite stage. Embryos injected with the IFT140
p.G212R-encoding change were worse than that of WT
rescue, but improved from the MO-injected batches
alone, indicating that it is a likely partial loss of
function variant (p < 0.0001 for all pairwise tests; n =
51–78 embryos/injection; repeated twice masked to in-
jection cocktail; Fig. 3d). We saw no significant differ-
ence between WT and p.Gly212Arg-encoding mRNA
alone. In sum, these data suggest that full-length
mRNA encoding IFT140 p.Gly212Arg has impaired
function.
Whole exome sequencing informs the origin of the
Mendelian error
The stretch of homozygosity on 16p13 was suggestive of a
partial uniparental isodisomy, and identification of a ma-
ternal, but not paternal, carrier of the IFT140 c.634G > A;
p.Gly212Arg allele was consistent with this hypothesis. To
explore further the basis of this chromosomal event, we
conducted trio-based whole sequencing. This experiment
offered us the opportunity not only to determine the par-
ental origin of the proband chromosome 16 but also to
test whether other variants elsewhere in the exome might
contribute to proband phenotype.
We generated 100-bp paired-end reads from exome
capture libraries corresponding to each of the proband,
mother, and father and conducted variant calling and
alignment as described [51]. All three exomes exceeded
our quality control thresholds with an average coverage
of 117x, and greater than 95% of target bases with ≥20x
coverage (Additional file 1: Table S2). We filtered vari-
ant data from each individual to retain functional vari-
ants (predicted to alter mRNA splicing or protein
sequence) with a MAF <1% in two public databases, the
National Heart, Lung and Blood Institute (NHLBI)
Exome Sequencing project (n = 6500 exomes) [52], and
the Atherosclerosis Risk in Communities cohort (ARIC;
n = 2300 exomes) [53]. Next, we compared trio exomes
to identify a final candidate gene list harboring rare
homozygous, compound heterozygous, X-linked, or de
novo variants. Reassuringly, we identified the same
homozygous c.634G>A variant in IFT140 discovered
previously by Sanger sequencing. We detected two add-
itional rare variants within the ~20-Mb stretch of
homozygosity on 16p13: a missense variant in ABCA3
(c.4420C>T, p.Arg1474Trp) and another change in
ABCC1 (c.569G>A, p.Cys190Tyr; Additional file 1:
Table S3). We also identified compound heterozygous
missense variants in ARHGEF10 (c.1601_1603delTGA,
p.Met535del het; c.3967C>T, p.Arg1323Trp het).
Although we cannot rule out the possibility that these
three genes might contribute to the proband pheno-
type, they harbor variants of unclear significance that
were either not associated previously with any human
condition (ABCC1 and ARHGEF10) or have reported
roles in human genetic disorders that do not overlap
with the proband phenotype (neonatal respiratory
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distress, ABCA3 [54, 55]). Thus, IFT140 remained the
most plausible genetic driver of disease.
Finally, we compared chromosome (chr) 16 variant
calls across the trio (Fig. 2d). To eliminate sequencing
artifacts, we set a stringent single nucleotide variant
(SNV) call threshold at ≥10 exome sequencing reads
and a quality score >30; 823 of such variants were
present in the proband with sufficient coverage to also
call the parental genotypes. The majority of variants
were uninformative because (1) the genotype was identi-
cal across all three individuals, (2) proband genotype
was homozygous and both parental genotypes were het-
erozygous, or (3) proband genotype was heterozygous
and one of the two parents was heterozygous. Next, we
asked how many SNVs were consistent with the
Mendelian violation paradigm observed for IFT140
c.634G>A. Not only did we identify 76 of such variants
within the 16p13 region reported by the oligo-SNP array,
but we also observed another 15 variants on the remain-
der of 16p and 20 variants on 16q that were homozy-
gous in the proband, heterozygous in the maternal
sample, and homozygous reference in the father (Fig. 2d).
Finally, we tested whether the proband harbored variants
that could only have been inherited paternally (not
present in the maternal sample); no variants fulfilled
these criteria. Importantly, we found an equivalent
contribution of rare variation (<1% MAF) from each
parent on all other autosomes, excluding the possibility
of non-paternity. In sum, our exome data indicate that
the proband has a chr16 maternal heterodisomy, with a
segmental isodisomy at 16p13 and suggest that an early
error in meiosis occurred in the maternal gamete.
Discussion
Here, we report a case with phenotypic features and a
molecular lesion consistent with Mainzer-Saldino
syndrome (MZSDS). This disorder, known historically as
conorenal dysplasia, is a rare disease characterized by
phalangeal cone-shaped epiphyses, chronic renal disease,
retinal dystrophy, and mild abnormalities of the prox-
imal femur [56]. Other features may include short
stature, hepatic fibrosis, and cerebellar ataxia. MZSDS
was first classified as a ciliopathy when recessive
mutations in IFT140 were reported to be causative [24],
and it is now known also to be caused by dysfunction of
IFT172 [26]. Three individuals from two unrelated
skeletal ciliopathy pedigrees also harbor c.634G>A;
p.Gly212Arg, but this allele is in trans with likely null
mutations (frameshifting (MZSDS) or canonical splice
mutation (JATD)) [24]. Based on this observation, we
predict that p.Gly212Arg retains at least partial function.
This is supported by reports from IFT gene mutations in
humans in which two loss of function mutations are
likely incompatible with life past early embryogenesis;
recessive null mutations are typically found in trans with
hypomorphic changes [15–19, 23–27, 43–47, 57, 58].
However, further studies on the protein level will be re-
quired to determine whether p.Gly212Arg produces a
stable and functional peptide. Although the phalangeal
cone-shaped epiphyses, renal phenotypes, and retinal de-
generation are consistent between our case and the two
reported siblings in family V with MZSDS [3], we note
the absence of any overt craniofacial dysmorphisms or
craniosynostosis in the case reported here (Table 1).
Based on the genetic complexity of the ciliopathies,
stochastic, or mutational burden in additional ciliary
genes might be contributing to these differences [13].
Our report also represents a rare case of a ciliopathy
caused by a segmental uniparental isodisomy. The inci-
dence of uniparental disomy (UPD), in which both
homologs of a chromosomal region are inherited from
one parent, is not exceedingly rare (estimated ~1:3500
live births [59]) and may not necessarily result in path-
ology. However, uniparental isodisomy, i.e., the inherit-
ance of a single copy of a parental chromosome or
chromosomal segment with concomitant homozygosity,
can potentially unmask recessive deleterious alleles
inherited from a carrier parent. This phenomenon was
first reported in cystic fibrosis in 1988 and is now a
recognized, albeit rare, mechanistic basis for inherited
disease [60]. There are multiple mechanisms proposed
to underlie UPD [61]. Based on the observation of
maternal chr16 heterodisomy with isodisomy at 16p13,
we consider two possibilities originating from meiosis I
error to be the most likely (1) gamete complementation
or (2) trisomy rescue. In gamete complementation,
fertilization of a disomic chr16 maternal gamete and a
nullisomic chr16 paternal gamete would have occurred.
In the latter possibility, a disomic chr16 maternal gam-
ete would have been fertilized by a normal male gamete,
and a mitotic rescue event would have rebalanced the
chromosome number. To determine the likelihood of a
trisomy rescue, we evaluated the exome reads covering
the 76 homozygous variants on 16p13 in the proband
(Fig. 2b, d) for evidence of mosaicism. The majority of var-
iants harbored exclusively alternate reads (49/76; 64%);
however, the remainder (27/76; 36%) had 1–3 reference
reads at positions annotated as homozygous (Additional
file 1: Figure S3). Mosaicism, if any, is likely to be low in
the proband, and deeper sequencing would be required to
confirm the possibility of a trisomy rescue.
Conclusions
In summary, we report the successful combination of
clinical evaluation and research-based genetic and func-
tional testing to render a molecular diagnosis of
Mainzer-Saldino syndrome.
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Additionally, we report a rare instance of a unipa-
rental isodisomy unmasking a deleterious mutation to
cause a ciliary disorder, highlighting the importance
of assessing Mendelian errors in both chromosomal
array and trio-based whole exome sequencing studies.
Methods
Clinical genetic testing
Panel sequencing was conducted in compliance with the
Clinical Laboratory Improvement Amendments (CLIA)
regulations as part of standard of care.
Bidirectional Sanger sequencing of coding regions and
intron-exon junctions was performed using standard
methodology as part of a nephrotic syndrome panel
(NPHS2, NPHS1, LAMB2, WT1, ACTN4, and TRPC6;
Athena Diagnostics, Worcester, MA) or nephronophthi-
sis panel (GLIS2, IQCB1, NPHP3, SDCCAG8, and INVS;
Prevention Genetics, Marshfield, WI). All test results
were reviewed, interpreted, and reported by ACMG-
certified Clinical Molecular Geneticists. Chromosome
microarray analysis was also performed in a CLIA envir-
onment as part of standard of care (Quest Diagnostics,
Chantilly, VA). The oligo-SNP array (Affymetrix 6.0)
contained over 1.8 million probes, including 900,000
copy-number probes and 900,000 SNP probes with an
average inter-probe distance of 700bp; calls were
made against the GRCh37/hg19 human genome as-
sembly. Thresholds for genome-wide screening were
set at >200 kb for gains and >50 kb for losses, and
the threshold used for calling regions of homozygosity
was set at >3–5 Mb.
Bidirectional sequencing of IFT140
Subsequent to informed consent for participation in re-
search, we obtained a blood sample from each member
of the trio and extracted DNA from lymphocytes
(Gentra Puregene Blood Kit, Qiagen). We PCR-amplified
coding regions and intron-exon boundaries and con-
ducted bidirectional cycle sequencing with BigDye v3.1
chemistry on an ABI3730 capillary sequencer. Sequen-
cing reads were aligned to reference and analyzed with
Lasergene (DNASTAR) software.
Lymphocyte cell culture and mRNA splicing studies
B cell lymphocytes were separated from whole-blood
samples and were transformed with Epstein-Barr virus
(EBV). We cultured cells in RPMI-1640 media supple-
mented with 10% fetal bovine serum. Wild type cell lines
originated from the NHGRI Sample Repository for
Human Genetic Research (GM19153; Coriell Institute).
We extracted total RNA from LCLs using Trizol reagent
(ThermoFisher), and 1 μg was DNAse treated and
reverse transcribed using the QuantiTect Reverse
Transcription kit (Qiagen). IFT140 exons 4–8 were
amplified and subjected to electrophoresis on a 2% gel,
and resulting fragments were gel purified (QIAquick Gel
Extraction kit; Qiagen) and sequenced.
Whole exome sequencing
We generated capture libraries and 100-bp paired-end
reads essentially as described [51]. Briefly, we frag-
mented genomic DNA by sonication, ligated it to Illu-
mina multiplexing PE adapters, and PCR-amplified
samples using primers with sequencing indexes. The
pre-capture library was then hybridized to biotin-
labeled VCRome 2.1 exome probes. Post-capture li-
brary DNA was then subjected to sequence analysis
on an Illumina Hiseq platform to generate ~9–12 Gb
of data. Output data were converted from bcl files to
FastQ files by Illumina CASAVA 1.8 software and
mapped to the hg19 reference genome by the Bur-
rows Wheeler Alignment (BWA) program. Variant
calling was performed using Atlas-SNP and Atlas-
Indel [62]. For chr16 variant comparisons, we used
Enlis Genome Research software to set thresholds
(≥10 exome sequencing reads and a quality score
>30) and extract genotype lists for each of the pro-
band, maternal, and paternal exome data. Variant read
depth and variant calls were confirmed visually with
the Integrated Genomics Viewer (IGV). Data were
visualized with PhenoGram (Center for System Genomics,
Pennsylvania State University; http://visualization.ritchielab.
psu.edu/).
Zebrafish manipulation and injections
A splice-blocking morpholino (Gene Tools) targeting
ift140 (5′-AGTGATCATGTCTTACCTGCTGCAG-′3)
[50] was injected at the indicated concentration into
wild-type zebrafish embryos at the one-to-four-cell stage
(1 nl/embryo; all injections repeated at least twice, with
masked scoring). To validate MO efficiency, we harvested
embryos in Trizol reagent at the eight-to-ten-somite stage,
extracted total RNA, and conducted RT-PCR studies as
described above for human lymphocyte cell lines. To gen-
erate human wild-type and mutant mRNA, we first cloned
the full-length open reading frame (ORF) (IOH56213;
Ultimate ORF, ThermoFisher) into a Gateway-compatible
pCS2+ plasmid using LR clonase II (ThermoFisher), line-
arized with Not I, and performed in vitro transcription
with the mMessage mMachine SP6 transcription kit
(ThermoFisher). For dose curve or rescue experiments,
embryos were scored live at the eight-to-ten-somite
stage using previously defined objective scoring criteria
[4, 23, 47]. Images were acquired on a Nikon AZ100
microscope facilitated by NIS Elements software. χ2
tests were used to perform statistical comparisons of
embryo batches in a pairwise manner.
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Additional file
Additional file 1: Table S1. Clinical genetic testing summary.
Table S2. Whole exome sequencing capture statistics. Table S3. Final
variant list following trio-based exome analysis (<1% minor allele
frequency (MAF), homozygous, compound heterozygous, de novo, or
X-linked). Figure S1. Fundus imaging and full field electroretinograms
indicate retinal dystrophy. a. Fundus imaging of the proband at 5 years
6 months in the right (top) and left (bottom) eyes show mottling of the
retinal pigmentary epithelium. b. Photopic (light adapted) testing of cone
function demonstrated reduced a-wave implicit time and amplitudes
with slowed implicit times for the b-wave. c. Scotopic (dark adapted)
testing of rod function demonstrated slower implicit time and diminished
amplitudes for both a- and b-waves. The a-wave was substantially delayed
with reduced incremental increases in a-wave and b-wave. Figure S2.
Validation of the ift140 splice-blocking (sb) morpholino (MO). a. Schematic
of the D. rerio ift140 locus at chr24:37,937,737-38,013,596 (GRCz10; top) and
translated protein (bottom). Exons are depicted as green boxes; untranslated
regions are shown as white boxes (ENSDART00000129889.4). The sb-MO
targets the splice donor of exon (Ex) 2 (red box). Protein schematic (blue)
indicates predicted WD40 repeat (WD40) and tetratricopeptide-like helical
domains (TPR). b. ift140 sb-MO induces aberrant splicing of endogenous
transcript. ift140 transcript was evaluated by RT-PCR; embryos were injected
with 9 ng MO at the one-to-four-cell stage and harvested for RNA extraction
at the mid-somitic stage. Resulting cDNA was amplified with primers flanking
the MO target site (arrows in panel a), and migrated on a 2.5% agarose
gel. β–actin was used as a control to ensure RNA integrity. c. Chromatograms
indicate splicing defects in ift140 mRNA in morphants. Sequence analysis of
purified PCR product indicates that the majority of ift140 message is missing
exon 2 (bottom), which contains the translation initiation codon. Modest
amounts of wild type (wt; center) and mRNA containing a 33 nucleotide
in-frame intronic insertion (top) are also detectable. d. Representative dose
curve of the ift140 sb-MO. Embryo batches were injected at the one-to-four-
cell stage with increasing amounts of ift140 sb-MO and scored for
gastrulation defects at the mid-somitic stage (eight to ten somites). Embryos
were scored live according to previously established phenotypic criteria: class
I, modest shortening of the body axis and reduction in size of anterior
structures; class II, severe shortening of the body axis and decreased anterior
structures accompanied by broadening and/or kinking of the notochord and
thinning of the somites (See Figure 3; n= 59–70 embryos/injection; repeated
twice). Figure S3. Read depth and variant calls of the homozygous variants
called on 16p13. Plot of the 76 maternally inherited homozygous variants
identified in the 16p13 region of the proband. Red indicates alternate (alt)
reads; blue indicates reference (ref) reads; 49/76 (64%) are comprised only of
alternate reads; 27/76 (36%) had one to three reference reads at positions
annotated as homozygous. (PDF 20018 kb)
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